Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan

Ken Nakajima, Omi Watanabe, Mayumi Mochizuki, Ayako Nakasone, Nobuhiko Ishizuka, Atsuko Murashima

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: To assess the effects of tocilizumab on pregnancy outcomes in Japanese patients with rheumatic disease. Methods: Data from Chugai’s tocilizumab safety database (April 2005 to October 2014) were retrospectively analyzed to identify pregnancy outcomes in patients exposed to tocilizumab. Results: Data were available for 61 pregnancies exposed to tocilizumab, and outcomes were reported for 50 of those pregnancies. In 36 births, no congenital anomalies were identified; however, six neonatal abnormalities were reported: five cases of low birth weight (

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalModern Rheumatology
DOIs
Publication statusAccepted/In press - 2016 Mar 3

Fingerprint

Pregnancy Outcome
Japan
Pregnancy
Low Birth Weight Infant
Rheumatic Diseases
Parturition
Databases
Safety
tocilizumab

Keywords

  • Abortions
  • Pregnancy outcome
  • Rheumatoid arthritis
  • Tocilizumab

ASJC Scopus subject areas

  • Rheumatology

Cite this

Nakajima, K., Watanabe, O., Mochizuki, M., Nakasone, A., Ishizuka, N., & Murashima, A. (Accepted/In press). Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Modern Rheumatology, 1-5. https://doi.org/10.3109/14397595.2016.1147405

Pregnancy outcomes after exposure to tocilizumab : A retrospective analysis of 61 patients in Japan. / Nakajima, Ken; Watanabe, Omi; Mochizuki, Mayumi; Nakasone, Ayako; Ishizuka, Nobuhiko; Murashima, Atsuko.

In: Modern Rheumatology, 03.03.2016, p. 1-5.

Research output: Contribution to journalArticle

Nakajima, Ken ; Watanabe, Omi ; Mochizuki, Mayumi ; Nakasone, Ayako ; Ishizuka, Nobuhiko ; Murashima, Atsuko. / Pregnancy outcomes after exposure to tocilizumab : A retrospective analysis of 61 patients in Japan. In: Modern Rheumatology. 2016 ; pp. 1-5.
@article{2e707c7520cd4b6c8b5d8089c5840670,
title = "Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan",
abstract = "Objectives: To assess the effects of tocilizumab on pregnancy outcomes in Japanese patients with rheumatic disease. Methods: Data from Chugai’s tocilizumab safety database (April 2005 to October 2014) were retrospectively analyzed to identify pregnancy outcomes in patients exposed to tocilizumab. Results: Data were available for 61 pregnancies exposed to tocilizumab, and outcomes were reported for 50 of those pregnancies. In 36 births, no congenital anomalies were identified; however, six neonatal abnormalities were reported: five cases of low birth weight (",
keywords = "Abortions, Pregnancy outcome, Rheumatoid arthritis, Tocilizumab",
author = "Ken Nakajima and Omi Watanabe and Mayumi Mochizuki and Ayako Nakasone and Nobuhiko Ishizuka and Atsuko Murashima",
year = "2016",
month = "3",
day = "3",
doi = "10.3109/14397595.2016.1147405",
language = "English",
pages = "1--5",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Pregnancy outcomes after exposure to tocilizumab

T2 - A retrospective analysis of 61 patients in Japan

AU - Nakajima, Ken

AU - Watanabe, Omi

AU - Mochizuki, Mayumi

AU - Nakasone, Ayako

AU - Ishizuka, Nobuhiko

AU - Murashima, Atsuko

PY - 2016/3/3

Y1 - 2016/3/3

N2 - Objectives: To assess the effects of tocilizumab on pregnancy outcomes in Japanese patients with rheumatic disease. Methods: Data from Chugai’s tocilizumab safety database (April 2005 to October 2014) were retrospectively analyzed to identify pregnancy outcomes in patients exposed to tocilizumab. Results: Data were available for 61 pregnancies exposed to tocilizumab, and outcomes were reported for 50 of those pregnancies. In 36 births, no congenital anomalies were identified; however, six neonatal abnormalities were reported: five cases of low birth weight (

AB - Objectives: To assess the effects of tocilizumab on pregnancy outcomes in Japanese patients with rheumatic disease. Methods: Data from Chugai’s tocilizumab safety database (April 2005 to October 2014) were retrospectively analyzed to identify pregnancy outcomes in patients exposed to tocilizumab. Results: Data were available for 61 pregnancies exposed to tocilizumab, and outcomes were reported for 50 of those pregnancies. In 36 births, no congenital anomalies were identified; however, six neonatal abnormalities were reported: five cases of low birth weight (

KW - Abortions

KW - Pregnancy outcome

KW - Rheumatoid arthritis

KW - Tocilizumab

UR - http://www.scopus.com/inward/record.url?scp=84961204382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961204382&partnerID=8YFLogxK

U2 - 10.3109/14397595.2016.1147405

DO - 10.3109/14397595.2016.1147405

M3 - Article

C2 - 26873562

AN - SCOPUS:84961204382

SP - 1

EP - 5

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

ER -